Profil
Ingrid Goldberg is currently working as an Investor Relations Contact at NovoCure Ltd.
Prior to this, she worked as a Director-Investor Relations at ABIOMED, Inc. from 2014 to 2019 and as a Vice President-Investor Relations at bluebird bio, Inc. from 2020 to 2021.
Aktive Positionen von Ingrid Goldberg
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVOCURE LIMITED | Investor Relations Contact | 01.07.2021 |
Ehemalige bekannte Positionen von Ingrid Goldberg
| Unternehmen | Position | Ende |
|---|---|---|
| BLUEBIRD BIO, INC. | Investor Relations Contact | 01.06.2021 |
| ABIOMED, INC. | Investor Relations Contact | 01.12.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
